MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studiesKuan-Lin Kuo, Kuo‐How Huang, I-Lin Ho et al.|Cancer Letters|2015Cited by 64
MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial CarcinomaI-Lin Ho, Kuo‐How Huang, Chien-Tso Chou et al.|Scientific Reports|2015Cited by 45
The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo StudyKuan-Lin Kuo, Kuo‐How Huang, Shing‐Hwa Liu et al.|Cells|2019Cited by 28
PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo StudyFu-Shun Hsu, Kuo‐How Huang, Wei‐Chou Lin et al.|International Journal of Molecular Sciences|2021Cited by 27
Neddylation inhibitor, MLN4924 suppresses angiogenesis in huvecs and solid cancers: <i>in vitro</i> and <i>in vivo</i> study.Chung‐Sheng Shi, Kuo‐How Huang, Kuan-Lin Kuo et al.|PubMed|2020Cited by 26